Login / Signup

Successful treatment of lupus protein-losing enteropathy with belimumab: A case report.

Marenori KojimaHironari HanaokaKaito AokiHiromi MatsushitaHiroshi ItoHidehiro Yamada
Published in: Modern rheumatology case reports (2024)
Lupus protein-losing enteropathy (LUPLE) is a rare condition in patients with systemic lupus erythematosus (SLE). Since the causes and exact pathological mechanism have not been elucidated, appropriate treatment has not been determined. Here, we report the case of a 69-year-old woman with systemic lupus erythematosus who developed LUPLE which was successfully treated with belimumab without an increase in glucocorticoid dose. This case suggests that belimumab monotherapy may be a treatment option for LUPLE.
Keyphrases
  • systemic lupus erythematosus
  • disease activity
  • combination therapy
  • rheumatoid arthritis
  • clinical trial
  • randomized controlled trial
  • amino acid
  • small molecule
  • open label
  • density functional theory